trial

A Trial of Cognitive Training in Schizophrenia

NCTId NCT02478827
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 83 (actual)
Sponsored by University of Calgary
Primary completion 2017-08-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
83 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2016-03-01
Primary completion
2017-08-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Cognitive training

Sponsors

University of CalgaryLead Sponsor

Sites

3 total
Calgary, CanadaCalgary, CanadaEdmonton, Canada

Facts & assertions

4 sourced
Enrollment
83
Phase
NA
Primary Completion Date
2017-08-31
Status
COMPLETED
relationships
The graph out of here
drug
Cognitive training
drug
lead_sponsor
University of Calgary
company
indication
Schizophrenia
indication
Schizophrenia
indication